← Leaderboards
Yannis Mantas Paulus
University Of Michigan At Ann Arbor
$3,015,077
Attributed
$4,907,566
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,907,566 · 4
By mechanism
R01$3,784,978 · 2
K08$897,588 · 1
R41$225,000 · 1
Top collaborators
- Chi Hwan Lee5 shared
- Xueding Wang3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Joseph Allen Potkay$5,131,560
- Carlos H Mastrangelo$1,837,172
- Jamille F Hetke$4,036,086
- Jaclynn Marie Hawkins$1,512,174
- Maria Anneke Woodward$3,880,882
Others in their field
Other Emerging Leaders on “Blindness”
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Susan Abushakra · Alzheon, Inc.$51,190,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Yunda Huang · Fred Hutchinson Cancer Center$18,031,840
- Andrew S Huhn · Johns Hopkins University$17,756,243
Research focus
BlindnessIn VivoOryctolagus CuniculusChoroidal NeovascularizationBlood VesselsImmunohistochemistryLasersTissuesInflammationComplexFluorescein AngiographyVascular Endothelial Growth FactorsCell InjuryContrast MediaRetinaSafetyHistologyPerformanceBiomaterial CompatibilityAge Related Macular DegenerationMacular DegenerationBiological MarkersAnimalsImage
Grant awards (13)
Multimodal Molecular Imaging of Choroidal Neovascularization$507,959
R01 · FY2025 · EY · contact PI
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug Delivery$382,435
R01 · FY2025 · EY
Multimodal Molecular Imaging of Choroidal Neovascularization$690,964
R01 · FY2024 · EY · contact PI
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug Delivery$382,556
R01 · FY2024 · EY
Multimodal Molecular Imaging of Choroidal Neovascularization$671,124
R01 · FY2023 · EY · contact PI
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug Delivery$382,556
R01 · FY2023 · EY
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug Delivery$371,079
R01 · FY2022 · EY
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug Delivery$396,305
R01 · FY2021 · EY
Real-time In Vivo Visualization of the Molecular Processes in Choroidal Neovascularization$224,397
K08 · FY2021 · EY · contact PI
Novel Nanosecond Laser and Ultrasound to Selectively Treat Eye Blood Vessels$225,000
R41 · FY2020 · EY · contact PI
Real-time In Vivo Visualization of the Molecular Processes in Choroidal Neovascularization$224,397
K08 · FY2020 · EY · contact PI
Real-time In Vivo Visualization of the Molecular Processes in Choroidal Neovascularization$224,397
K08 · FY2019 · EY · contact PI
Real-time In Vivo Visualization of the Molecular Processes in Choroidal Neovascularization$224,397
K08 · FY2018 · EY · contact PI